Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study

被引：91
|
作者：
Qin, Shukui
Chen, Zhendong
Fang, Weijia
Ren, Zhenggang
Xu, Ruocai
Ryoo, Baek-Yeol
Meng, Zhiqiang
Bai, Yuxian
Chen, Xiaoming
Liu, Xiufeng
Xiao, Juxiang
Ho, Gwo Fuang
Mao, Yimin
Ye, Xing
Ying, Jieer
Li, Jianfeng
Zhong, Wen Yan
Zhou, Yu
Siegel, Abby B.
Hao, Chunyi
机构：
[1] Nanjing Chinese Med Univ, Jinling Hosp, Ctr Canc, Nanjing, Peoples R China
[2] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[3] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[5] Hunan Canc Hosp, Changsha, Peoples R China
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[7] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[8] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China
[9] Guangdong Prov Peoples Hosp, Dept Intervent Radiol, Guangzhou, Peoples R China
[10] Chinese PLA, Eastern Theater Gen Hosp, Nanjing, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaaxi, Peoples R China
[12] Univ Malaya, Dept Clin Oncol, Fac Med, Kuala Lumpur, Malaysia
[13] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[14] Deyang Hosp, Deyang, Peoples R China
[15] Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp,Inst Canc & Basic Med IBMC, Hangzhou, Zhejiang, Peoples R China
[16] MSD China, Beijing, Peoples R China
[17] MSD China, Shanghai, Peoples R China
[18] Columbia Univ, New York, NY USA
[19] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
383
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
    Bellmunt, J.
    Fougeray, R.
    Rosenberg, J. E.
    von der Maase, H.
    Schutz, F. A.
    Salhi, Y.
    Culine, S.
    Choueiri, T. K.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1466 - 1472
  • [42] Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240
    Merle, P.
    Kulkarni, A. S.
    Ryoo, B-Y.
    Cheng, A-L.
    Kudo, M.
    Bouattour, M.
    Lim, H. Y.
    Breder, V.
    Edeline, J.
    Chao, Y.
    Ogasawara, S.
    Yau, T.
    Garrido, M.
    Chan, S.
    Daniele, B.
    Norquist, J.
    Chen, E.
    Siegel, A. B.
    Zhu, A. X.
    Finn, R. S.
    ANNALS OF ONCOLOGY, 2019, 30 : 256 - 256
  • [43] Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients
    Caballero-Banos, Miguel
    Benitez-Ribas, Daniel
    Tabera, Jaime
    Varea, Sara
    Vilana, Ramon
    Bianchi, Luis
    Ramon Ayuso, Juan
    Pages, Mario
    Carrera, Gemma
    Cuatrecasas, Miriam
    Martin-Richard, Marta
    Cid, Joan
    Lozano, Miguel
    Castells, Antoni
    Garcia-Albeniz, Xabier
    Maurel, Joan
    Vilella, Ramon
    EUROPEAN JOURNAL OF CANCER, 2016, 64 : 167 - 174
  • [44] Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
    Garcia-Donas, Jesus
    Font, Albert
    Perez-Valderrama, Begona
    Antonio Virizuela, Jose
    Angel Climent, Miquel
    Hernando-Polo, Susana
    Angel Arranz, Jose
    del Mar Llorente, Maria
    Lainez, Nuria
    Carlos Villa-Guzman, Jose
    Mellado, Begona
    Gonzalez del Alba, Aranzazu
    Castellano, Daniel
    Gallardo, Enrique
    Anido, Urbano
    Garcia del Muro, Xavier
    Domenech, Montserrat
    Puente, Javier
    Morales-Barrera, Rafael
    Luis Perez-Gracia, Jose
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2017, 18 (05): : 672 - 681
  • [45] Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
    Vickers, M. M.
    Karapetis, C. S.
    Tu, D.
    O'Callaghan, C. J.
    Price, T. J.
    Tebbutt, N. C.
    Van Hazel, G.
    Shapiro, J. D.
    Pavlakis, N.
    Gibbs, P.
    Blondal, J.
    Lee, U.
    Meharchand, J. M.
    Burkes, R. L.
    Rubin, S. H.
    Simes, J.
    Zalcberg, J. R.
    Moore, M. J.
    Zhu, L.
    Jonker, D. J.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 953 - 960
  • [46] Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial
    Qin, Shukui
    Chen, Zhendong
    Fang, Weijia
    Ren, Zhenggang
    Xu, Ruocai
    Ryoo, Baek-Yeol
    Meng, Zhiqiang
    Bai, Yuxian
    Chen, Xiaoming
    Liu, Xiufeng
    Xiao, Juxiang
    Ho, Gwo Fuang
    Mao, Yimin
    Wang, Xin
    Ying, Jieer
    Li, Jianfeng
    Zhong, Wenyan
    Zhou, Yu
    Siegel, Abby B.
    Hao, Chunyi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1434 - +
  • [47] Irinotecan versus best supportive care (BSC) as second-line therapy in gastric cancer: A randomized phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    Thuss-Patience, P. C.
    Kretzschmar, A.
    Deist, T.
    Hinke, A.
    Bichev, D.
    Lebedinzew, B.
    Schumacher, G.
    Gebauer, B.
    Maier, V.
    Reichardt, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Comparative efficacy of S-1 versus best supportive care in advanced hepatocellular carcinoma.
    Yu, Pengfei
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [49] Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Zhong, Chenxi
    Liu, Hongcheng
    Jiang, Liyan
    Zhang, Wei
    Yao, Feng
    PLOS ONE, 2013, 8 (03):
  • [50] The comparative safety and efficacy of S-1 versus the best supportive care in advanced hepatocellular carcinoma
    Du, Yian
    Yu, Pengfei
    Huang, Ling
    Dai, Gaiguo
    Cai, Xiujun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5412 - 5418
12345